Cantuzumab mertansine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cantuzumab mertansine?
Mertansine mab structure.svg
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target MUC1
Clinical data
Identifiers
400010-39-1 N
None
UNII 7Z7EUX7R6M N
Chemical data
 N (what is this?)  (verify)

Cantuzumab mertansine is an antibody-drug conjugate used to treat colorectal cancer and other types of cancer.[1] It is a humanized monoclonal antibody, cantuzumab linked to a cytotoxic agent, mertansine.

Three phase I clinical studies had reported results by 2003.[2]

See also[edit]

References[edit]

  1. ^ Statement On A Nonproprietary Name Adopted By The Usan Council - Cantuzumab mertansine, American Medical Association.
  2. ^ http://phx.corporate-ir.net/phoenix.zhtml?c=97573&p=irol-newsArticle&ID=354351&highlight=